Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1849 1
1894 1
1966 1
1967 2
1969 1
1974 1
1976 1
1977 1
1981 1
1982 1
1986 2
1988 2
1992 2
1993 1
1994 1
1996 1
1997 1
1998 1
1999 1
2002 1
2004 2
2005 2
2006 4
2007 3
2008 2
2009 2
2010 2
2011 6
2012 5
2013 9
2014 5
2015 4
2016 6
2017 2
2018 4
2019 5
2020 10
2021 7
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

92 results
Results by year
Filters applied: . Clear all
Page 1
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Liu X, Shaw RH, Stuart ASV, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Dinesh T, England A, Faust SN, Ferreira DM, Finn A, Green CA, Hallis B, Heath PT, Hill H, Lambe T, Lazarus R, Libri V, Long F, Mujadidi YF, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Singh N, Turner DPJ, Turner PJ, Walker LL, White R, Nguyen-Van-Tam JS, Snape MD; Com-COV Study Group. Liu X, et al. Among authors: cameron jc. Lancet. 2021 Sep 4;398(10303):856-869. doi: 10.1016/S0140-6736(21)01694-9. Epub 2021 Aug 6. Lancet. 2021. PMID: 34370971 Free PMC article. Clinical Trial.
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Stuart ASV, Shaw RH, Liu X, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Darton T, Dinesh T, Duncan CJA, England A, Faust SN, Ferreira DM, Finn A, Goodman AL, Green CA, Hallis B, Heath PT, Hill H, Horsington BM, Lambe T, Lazarus R, Libri V, Lillie PJ, Mujadidi YF, Payne R, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Screaton GR, Singh N, Turner DPJ, Turner PJ, Vichos I, White R, Nguyen-Van-Tam JS, Snape MD; Com-COV2 Study Group. Stuart ASV, et al. Among authors: cameron jc. Lancet. 2022 Jan 1;399(10319):36-49. doi: 10.1016/S0140-6736(21)02718-5. Epub 2021 Dec 6. Lancet. 2022. PMID: 34883053 Free PMC article. Clinical Trial.
Life cycle of a cyanobacterial carboxysome.
Hill NC, Tay JW, Altus S, Bortz DM, Cameron JC. Hill NC, et al. Among authors: cameron jc. Sci Adv. 2020 May 6;6(19):eaba1269. doi: 10.1126/sciadv.aba1269. eCollection 2020 May. Sci Adv. 2020. PMID: 32494723 Free PMC article.
Mechanical regulation of photosynthesis in cyanobacteria.
Moore KA, Altus S, Tay JW, Meehl JB, Johnson EB, Bortz DM, Cameron JC. Moore KA, et al. Among authors: cameron jc. Nat Microbiol. 2020 May;5(5):757-767. doi: 10.1038/s41564-020-0684-2. Epub 2020 Mar 23. Nat Microbiol. 2020. PMID: 32203409
Public policy for meningococcal vaccination.
Cameron JC. Cameron JC. Hum Vaccin Immunother. 2018 May 4;14(5):1216-1217. doi: 10.1080/21645515.2017.1403701. Epub 2018 Jan 16. Hum Vaccin Immunother. 2018. PMID: 29194013 Free PMC article.
TAG… You're It, Synechocystis sp. PCC 6803!
Cameron JC. Cameron JC. Plant Cell Physiol. 2020 Sep 1;61(9):1535-1536. doi: 10.1093/pcp/pcaa105. Plant Cell Physiol. 2020. PMID: 32777819 No abstract available.
Genome engineering of E. coli for improved styrene production.
Liang L, Liu R, Foster KEO, AlakshChoudhury, Cook S, Cameron JC, Srubar WV 3rd, Gill RT. Liang L, et al. Among authors: cameron jc. Metab Eng. 2020 Jan;57:74-84. doi: 10.1016/j.ymben.2019.09.007. Epub 2019 Sep 13. Metab Eng. 2020. PMID: 31525473
92 results